| Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961) |
|---|
| 04/18/2001 | EP1091739A1 Method for inhibiting c-jun expression using jak-3 inhibitors |
| 04/17/2001 | US6218534 Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate |
| 04/17/2001 | US6218375 Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-β-cyclodextrin or 2-hydroxypropyl-β-cyclodextrin and method |
| 04/11/2001 | EP1089981A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis. |
| 04/11/2001 | EP1089980A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| 04/11/2001 | EP1089977A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| 04/11/2001 | CN1064354C Trilcyclic benzazepine vasopressin antagnonists |
| 04/10/2001 | US6214823 Benzodiazepine derivatives as antiarrhythmic agents |
| 04/10/2001 | US6214822 Substituted aza and diazacycloheptane and cyclooctane compounds and their use |
| 04/05/2001 | WO2000073284A3 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors |
| 04/04/2001 | CN1290254A Sulfonamide derivatives process for producing the same and utilization thereof |
| 04/03/2001 | US6211228 Compositions and methods for treating mast-cell mediated conditions |
| 04/03/2001 | US6211183 Selective factor Xa inhibitors |
| 03/28/2001 | EP1086076A1 Sulfonamide inhibitors of aspartyl protease |
| 03/28/2001 | CN1289324A Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound |
| 03/27/2001 | US6207663 Vitronectin receptor antagonists, their preparation and use |
| 03/22/2001 | WO2001019797A2 HYDROXYALKANOYL AMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 03/22/2001 | WO2000063195A8 Novel heterocyclic amino carbonyl derivatives useful as nitric oxide synthase inhibitors |
| 03/22/2001 | WO2000001376A3 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| 03/22/2001 | CA2377221A1 Hydroxyalkanoyl aminolactams and related structures as inhibitors of a.beta. protein production |
| 03/21/2001 | EP1085014A1 1,5-benzodiazepine derivatives |
| 03/20/2001 | US6204262 1,3-Benzodiazepin-2-ones and 1,3-Benzoxazepin-2-ones useful as HIV reverse transcriptase inhibitors |
| 03/20/2001 | US6204261 Inhibitors of interleukin-1β Converting enzyme inhibitors |
| 03/15/2001 | WO1999065870A3 Sulfonamide inhibitors of aspartyl protease |
| 03/13/2001 | US6201119 Antiretroviral tetrahydroimidazo[1,4]benzodiazepin-2(thi) ones |
| 03/13/2001 | US6200970 For treating a disease associated with overstimulation of an ampa receptor, or hyperactivity of an excitatory amino acid |
| 03/08/2001 | WO2001016110A1 Bleach boosting components, compositions and laundry methods |
| 03/08/2001 | WO2001015656A2 Tricyclic compounds and their uses as antiarrhythmic antifibrillatory and defibrillatory agents |
| 03/08/2001 | CA2381892A1 Bleach boosting components, compositions and laundry methods |
| 03/07/2001 | EP1080077A1 Substituted 1,3-diaza-2-(thi)oxo-cycloalkanes |
| 03/06/2001 | US6197764 Clozapine compositions and uses thereof |
| 03/01/2001 | WO2000071516B1 INHIBITORS OF FACTOR Xa |
| 03/01/2001 | WO2000068209A3 1,5-benzodiazepine derivatives as cck-a receptor agonists |
| 02/22/2001 | WO2001012600A1 INHIBITORS OF FACTOR Xa |
| 02/15/2001 | WO2001010847A2 Novel integrin receptor antagonists |
| 02/15/2001 | WO2001010846A2 1,4-diazepine derivatives for the treatment of diseases related to the central nervous system |
| 02/15/2001 | WO2001010799A1 Methods for preparing n-[(aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
| 02/15/2001 | WO2001010797A1 Process for catalyzing the oxidation of organic compounds |
| 02/15/2001 | WO2001010216A1 Antiarrhythmic compounds |
| 02/15/2001 | DE19936780A1 Neue Antagonisten von Integrinrezeptoren New antagonists of integrin |
| 02/15/2001 | CA2381260A1 Novel 1,4-benzodiazepine compounds and derivatives thereof |
| 02/15/2001 | CA2380851A1 Process for catalyzing the oxidation of organic compounds |
| 02/15/2001 | CA2379977A1 Novel integrin receptor antagonists |
| 02/08/2001 | WO2001055118A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient |
| 02/07/2001 | EP1073644A1 Solid supported synthesis of sulfonated 2-oxopiperazines |
| 01/31/2001 | EP1072587A1 Sulfonamide derivatives and drugs containing the same as the active ingredient |
| 01/31/2001 | CN1282322A 1,4-diazacycloheptane derivatives |
| 01/25/2001 | WO2000071515A3 INHIBITORS OF FACTOR Xa |
| 01/24/2001 | EP0694039B1 1,5-benzodiazepine derivatives having cck antagonistic and or agonistic activity |
| 01/18/2001 | WO2001004122A2 New 2,3-benzodiazepine derivatives |
| 01/18/2001 | WO2001004103A1 Benzazepinones and quinazolines |
| 01/18/2001 | WO2000071516A3 INHIBITORS OF FACTOR Xa |
| 01/18/2001 | CA2378305A1 New 2,3-benzodiazepine derivatives |
| 01/11/2001 | WO2001002403A1 METHOD FOR PREPARING SUBSTITUTED [1,4]DIAZEPINO[6,7,1-hi]INDOL-4-ONES |
| 01/11/2001 | WO2001002381A1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/11/2001 | WO2001002373A1 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 01/11/2001 | WO2001002372A1 Cyclized amino acid derivatives |
| 01/11/2001 | WO2001002358A2 Cyclized amide derivatives for treating or preventing neuronal damage |
| 01/11/2001 | CA2376707A1 Process for the preparation of substituted ¬1,4|diazepino¬6,7,1-hi|indol-4-ones |
| 01/10/2001 | EP1067103A2 Process for producing halogenated benzene compound |
| 01/09/2001 | US6172059 Controlling particle size |
| 01/04/2001 | WO2001000625A1 Process for the preparation of imidazodiazepine intermediates |
| 01/04/2001 | CA2341524A1 Process for the preparation of imidazodiazepine intermediates |
| 01/03/2001 | EP1064300A1 Peptide turn mimetics |
| 01/03/2001 | EP1064274A1 Benzenesulfonamide derivatives and their use as medicaments |
| 01/03/2001 | CN1278797A Oxo-substituted compouns, process of making, and compositions and methods for inhibiting parp activity |
| 01/02/2001 | US6169084 2-methyl-thieno-benzodiazepine formulation |
| 12/28/2000 | WO2000078744A1 Thiochroman derivatives against neurological disorders |
| 12/28/2000 | WO2000078736A1 1,4-diazacycloheptane derivatives as neuroprotective agents |
| 12/28/2000 | WO2000078725A1 Synthesis of substituted amidines |
| 12/27/2000 | EP1062210A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 12/26/2000 | US6166005 Heterocyclic metalloprotease inhibitors |
| 12/26/2000 | US6165230 For dyeing keratinous fibers; brilliance, color tone, colorfastness, thermal stability, level dyeing |
| 12/21/2000 | WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS |
| 12/20/2000 | EP1060169A1 1,4-diazacycloheptane derivatives |
| 12/20/2000 | CN1277604A Heteraryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
| 12/12/2000 | US6160133 Stereospecific biosynthesis of the alcohol by enzymatic reduction of the corresponding aldehyde or ketone using a candida, zygosaccaromyces, or mortierrela microorganism |
| 12/07/2000 | WO2000073284A2 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors |
| 12/07/2000 | CA2370141A1 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors |
| 12/06/2000 | EP1056727A1 Solid support synthesis of 2-oxopiperazines |
| 12/06/2000 | CN1275912A Novel amide derivatives |
| 12/05/2000 | CA2195974C 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines |
| 11/30/2000 | WO2000071518A2 Heterocyclic analgesic compounds and their use |
| 11/30/2000 | WO2000071516A2 INHIBITORS OF FACTOR Xa |
| 11/30/2000 | WO2000071515A2 INHIBITORS OF FACTOR Xa |
| 11/30/2000 | CA2374788A1 Inhibitors of factor xa |
| 11/30/2000 | CA2372887A1 Heterocyclic analgesic compounds and their use |
| 11/30/2000 | CA2371904A1 Inhibitors of factor xa |
| 11/23/2000 | WO2000069836A1 Short-acting benzodiazepines |
| 11/23/2000 | WO2000069835A2 Process for manufacturing diazepine derivatives |
| 11/23/2000 | WO2000069830A1 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
| 11/23/2000 | CA2373590A1 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
| 11/22/2000 | EP1054005A1 Sulfonamide derivatives, process for producing the same and utilization thereof |
| 11/22/2000 | CN1058710C Benzamide derivatives, process for prepn. thereof and pharmaceutical compsn. comprising same |
| 11/21/2000 | US6150370 1,3-dinitrocyclic compound treats numerous diseases caused by undesired metalloprotease activity, such as tumor metastasis, osteoarthritis, rheumatoid arthritis, skin inflammation, ulcerations, and periodontitis |
| 11/16/2000 | WO2000068209A2 1,5-benzodiazepine derivatives as cck-a receptor agonists |
| 11/16/2000 | CA2370801A1 1,5-benzodiazepine derivatives as cck-a receptor agonists |
| 11/15/2000 | EP1051407A1 2,3,4,5-tetrahydro-1h-[1,4]-benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
| 11/15/2000 | EP1051397A1 Method for preparing an n- (aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound |
| 11/15/2000 | CN1273586A Method for preparation of asymmetric cyclic ureas through monoaylated diamine |